Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |